The invention relates to new pharmaceutical formulations that have controlled delayed active ingredient release and to a method for producing such formulations. The invention further relates to the use of these new galenic dosage forms as drugs for treating diseases that require a delayed release of the active ingredient such as hypertension or asthmatic diseases.